Agilent Technologies, Inc.: Form 10-Q for the period ended Jul 31, 2017
Filed with the SEC on Sep 6, 2017 and accepted by EDGAR at Sep 6, 2017, 16:13 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-07-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Cost of revenue | 3 months2017-05-01 to 2017-07-31 | $518.0m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2016-11-01 to 2017-07-31 | $1.52bn | us-gaap:CostOfRevenue |
| Research and development | 3 months2017-05-01 to 2017-07-31 | $87.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2016-11-01 to 2017-07-31 | $250.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2017-05-01 to 2017-07-31 | $308.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2016-11-01 to 2017-07-31 | $904.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2017-05-01 to 2017-07-31 | $201.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2016-11-01 to 2017-07-31 | $608.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2017-05-01 to 2017-07-31 | $19.0m | us-gaap:InterestExpense |
| Interest expense | 9 months2016-11-01 to 2017-07-31 | $59.0m | us-gaap:InterestExpense |
| Income tax | 3 months2017-05-01 to 2017-07-31 | $18.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2016-11-01 to 2017-07-31 | $70.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2017-05-01 to 2017-07-31 | $175.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2016-11-01 to 2017-07-31 | $507.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2017-05-01 to 2017-07-31 | $0.54 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2016-11-01 to 2017-07-31 | $1.56 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2017-05-01 to 2017-07-31 | $0.55 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2016-11-01 to 2017-07-31 | $1.57 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2017-05-01 to 2017-07-31 | 326,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2016-11-01 to 2017-07-31 | 325,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2016-11-01 to 2017-07-31 | $601.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2016-11-01 to 2017-07-31 | $118.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2017-05-01 to 2017-07-31 | $42.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Dividends paid | 9 months2016-11-01 to 2017-07-31 | $127.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2016-11-01 to 2017-07-31 | $194.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2017-07-31 | $2.56bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-07-31 | $4.00bn | us-gaap:AssetsCurrent |
| Total assets | At period end2017-07-31 | $8.26bn | us-gaap:Assets |
| Current liabilities | At period end2017-07-31 | $1.24bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2017-07-31 | $3.65bn | us-gaap:Liabilities |
| Long-term debt | At period end2017-07-31 | $1.80bn | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | At period end2017-07-31 | $280.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2017-07-31 | $4.61bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001090872-17-000013. Last ingested by Listed: Oct 24, 2026, 15:02 ET. Listed shows no prices and gives no investment advice.